Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League …

C Dejaco, YP Singh, P Perel, A Hutchings… - Annals of the …, 2015 - ard.bmj.com
To summarise evidence on therapeutic interventions and prognostic factors in polymyalgia
rheumatica (PMR). A systematic literature review was conducted using Ovid Medline …

Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature …

A Floris, M Piga, E Chessa, M Congia, GL Erre… - Clinical …, 2022 - Springer
A systematic review and meta-analysis were conducted, according to the PRISMA
methodology, to summarize current evidence on the prevalence and predictors of long-term …

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative …

C Dejaco, YP Singh, P Perel, A Hutchings… - Annals of the …, 2015 - ard.bmj.com
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international
recommendations for PMR treatment are not currently available. In this paper, we report the …

Treatment of polymyalgia rheumatica: a systematic review

J Hernandez-Rodriguez, MC Cid… - Archives of Internal …, 2009 - jamanetwork.com
Background Polymyalgia rheumatica (PMR) treatment is based on low-dose glucocorticoids.
Glucocorticoid-sparing agents have also been tested. Our objective was to systematically …

PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo …

DE Marsman, TE Bolhuis, N den Broeder… - Trials, 2022 - Springer
Background Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease affecting
people older than 50, resulting in pain and stiffness of the neck, shoulder, and pelvic girdle …

Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study

SL Mackie, EMA Hensor, G Haugeberg… - …, 2010 - academic.oup.com
Objective. To identify the features of PMR that may predict the duration of steroid therapy, the
occurrence of relapses and the late development of GCA. Methods. Prospective cohort study …

S3 guidelines on treatment of polymyalgia rheumatica: Evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of …

F Buttgereit, DGRh, T Brabant, DGG, H Dinges… - Zeitschrift für …, 2018 - Springer
Polymyalgia rheumatica (PMR) occurs almost exclusively in persons aged 50 years or older
and it is the second most common inflammatory rheumatic disease in older people after …

Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study

RJ Partington, S Muller, T Helliwell… - Annals of the …, 2018 - ard.bmj.com
Objective Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic
disease in older people. Contemporary estimates of the incidence and prevalence are …

Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR

SL Mackie, S Arat, J Da Silva, C Duarte… - The Journal of …, 2014 - jrheum.org
We worked toward developing a core outcome set for clinical research studies in
polymyalgia rheumatica (PMR) by conducting (1) patient consultations using modified …

Development of a provisional core domain set for polymyalgia rheumatica: report from the OMERACT 12 Polymyalgia Rheumatica Working Group

T Helliwell, E Brouwer, CT Pease, R Hughes… - The Journal of …, 2016 - jrheum.org
Objective. The Outcome Measures in Rheumatology (OMERACT) polymyalgia rheumatica
(PMR) working group aims to develop a core set of outcome measures to be used in clinical …